Stock listing

Aurinia Pharmaceuticals Inc

Selected listing: 0UJF · LSE · CAD · GB

Aurinia Pharmaceuticals Inc (LSE:0UJF), Health Technology. Latest release Aug 6, 2026: Aurinia Pharmaceuticals Reports Financial Results for the Three and Six…

0UJF:LSECADGBUpdated October 2, 2026

Ticker: LSE:0UJF
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LSE
Currency: CAD

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc (Ticker: AUPH) is a public company based in the United States, focused on developing innovative therapies for kidney diseases. The company is committed to addressing unmet medical needs in the healthcare sector.

Latest news from Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress

August 6, 2026

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis

July 6, 2026

LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death

June 3, 2026

TANG CAPITAL MANAGEMENT, LLC FILES EARLY WARNING REPORT RESPECTING AURINIA PHARMACEUTICALS INC.

June 3, 2026

Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences

May 19, 2026

All Aurinia Pharmaceuticals Inc news →

Events

Replays

Aurinia Pharmaceuticals Inc (AUPH) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch
Aurinia Pharmaceuticals Inc (AUPH) Q3 2025 Earnings Call
Tue, Nov 04, 2025 · 08:30 AM ET
Watch
Aurinia Pharmaceuticals Inc (AUPH) Q2 2025 Earnings Call
Thu, Jul 31, 2025 · 08:30 AM ET
Watch

Research Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc company profile

View the public company page for Aurinia Pharmaceuticals Inc on 6ix.

Aurinia Pharmaceuticals Inc news

Read company news and market updates connected to Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc investor events

Find investor webinars, events, and replay context for Aurinia Pharmaceuticals Inc.